Bio-Rad Laboratories (BIO) Total Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Total Liabilities data on file, last reported at $2.9 billion in Q1 2026.

• On a quarterly basis, Total Liabilities rose 3.2% year-over-year to $2.9 billion in Q1 2026; TTM through Mar 2026 was $2.9 billion, a 3.2% increase from a year earlier, with the FY2025 full-year figure at $3.1 billion, up 11.74% from the prior year.
• Total Liabilities for Q1 2026 stood at $2.9 billion, down from $3.1 billion in the prior quarter.
• Over the last five years, Total Liabilities for BIO reached as high as $4.2 billion in Q1 2022 and fell as low as $2.8 billion in Q4 2024.
• Historically, Total Liabilities has averaged $3.4 billion across 5 years, with a median of $3.5 billion in 2023.
• On a YoY basis, Total Liabilities climbed as much as 26.07% in 2022 and fell as far as 21.99% in 2022.
• Year by year, Total Liabilities stood at $3.9 billion in 2022, then dropped by 8.45% to $3.6 billion in 2023, then dropped by 21.45% to $2.8 billion in 2024, then increased by 11.74% to $3.1 billion in 2025, then fell by 5.9% to $2.9 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $2.9 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.0 billion in Q3 2025.